Free ASCP HTL Practice Test

D. High-pH Tris-EDTA can improve retrieval for some antibodies, but more aggressive retrieval conditions can worsen morphology, tissue adhesion, and background. Formalin cross-links can mask epitopes; HIER uses heat in a retrieval solution to restore staining for many assays. Retrieval performance depends on the antibody and protocol, and stronger conditions can trade better signal for tissue damage or background. No single retrieval condition suits every antibody, so buffer, pH, heating and section adhesion are optimized per assay.

Why not the others: A describes proteolytic retrieval (PIER), not HIER. C is wrong; buffer pH is one of the main retrieval variables. B is wrong; neither buffer is universally stronger.

Source: Fortis Life Sciences, "Retrieval buffers: citrate vs Tris-EDTA", HIER, Citrate and Tris-EDTA sections.

C. No; antigen deterioration from prolonged cold ischemia cannot be recovered by antigen retrieval. Cold ischemic time runs from tissue acquisition to placement in fixative. The current ASCO/CAP ER/PgR recommendation says that interval should be as short as possible and that samples are fixed in 10% neutral buffered formalin for 6–72 hours. The Dako/Agilent IHC guidebook notes that epitope deterioration from ischemia cannot be recovered with antigen retrieval. Record the delay so the preanalytic limitation is visible when the result is interpreted. (Dry tissue also creates additional staining problems.)

Why not the others: Retrieval of any kind (A, B) reverses fixation-induced masking, not autolytic loss. Refixing in another fixative (D) can't restore degraded antigen and adds an unvalidated variable.

Source: ASCO/CAP, Estrogen and Progesterone Receptor Testing in Breast Cancer: Guideline Update, Recommendation 1.3; Taylor & Rudbeck (eds), Dako/Agilent IHC Staining Methods, 6th ed., Ch. 2.2, Tissue Handling, "Cold Ischemic Time," p. 21.

C. Thicker sections can cause staining difficulty and interpretation problems because cells overlap in multiple layers. Unless a protocol specifies otherwise, sections for IHC or ISH are usually cut at 3, 4 or 5 µm. Thicker sections multilayer cells, which complicates both staining and reading the result.

Why not the others: A ignores the multilayering problem. B and D overstate the effect; thick sections can adhere and be retrieved, they just stain and read poorly.

Source: Dako/Agilent IHC Staining Methods, 6th ed., Ch. 2.4, Tissue and Slide Processing, "Section Preparation," p. 25.

B. A lower-melting paraffin (about 45 °C). Low-melting-point waxes (around 45 °C), compared with higher-melting waxes (around 65 °C), have been reported to produce better IHC results, particularly for T-lymphocyte staining. Heat during infiltration is one of the pre-analytical variables that can affect antigenicity.

Why not the others: A is the opposite of the reported finding. C isn't a routine paraffin-processing option. D is contradicted by the published observation.

Source: Dako/Agilent IHC Staining Methods, 6th ed., Ch. 2.4, "Tissue Processing," p. 25.

D. OSHA's limits are an action level of 0.5 ppm (8-hour TWA), a PEL of 0.75 ppm (8-hour TWA), and a STEL of 2 ppm (15 minutes). A TWA under the action level doesn't excuse a STEL exceedance. Where the STEL is exceeded, the employer must establish a regulated area with the required signs, use engineering and work-practice controls, provide medical surveillance, and repeat monitoring at least once a year under worst conditions.

Why not the others: A ignores the STEL. C is false; 0.4 ppm is below the 0.75 ppm PEL. B is wrong; respirators supplement controls, and monitoring can stop only after two consecutive results at least 7 days apart fall below both the action level and the STEL.

Source: OSHA 29 CFR 1910.1048, Formaldehyde, (b) action level; (c)(1)–(2) PEL and STEL; (d)(3)(iii) and (d)(4) monitoring; (e)(1) regulated areas; (f) controls; (l)(1)(i) medical surveillance.

A. Luxol fast blue with a cresyl violet counterstain. Luxol fast blue demonstrates myelin, and cresyl violet identifies neuronal cell bodies. The pairing (LFB/cresyl echt violet) is on ASCP's HT/HTL stain list.

Why not the others: Congo red (B) is for amyloid. Mucicarmine (C) is for mucin and cryptococcal capsules. Oil red O (D) needs frozen sections and shows neutral lipid.

Source: Kumar & Kiernan (eds), Dako/Agilent Special Stains and H&E, 2nd ed., Ch. 1, Table 2 (Luxol fast blue; cresyl violet), p. 9; ASCP BOC HT/HTL Content Guideline (testing from Nov 1, 2026), Summary of Stains, p. 6.

B. Formalin penetrates tissue faster than its cross-linking reactions occur. NBF fixes by penetrating tissue and forming cross-links between reactive amino groups in proteins. Each of those reactions proceeds at its own rate, and all are slower than penetration. That gap is why "the formalin has gotten in" doesn't mean the tissue is fixed, and why minimum fixation times exist.

Why not the others: Coagulation (A) describes alcohol fixation. C isn't how formalin fixes; the buffer only holds the pH. D is false; formalin's fixation chemistry described here involves proteins.

Source: Dako/Agilent IHC Staining Methods, 6th ed., Ch. 2.3, Fixation, "10% NBF," p. 23.

D. A molecular sectioning SOP resets the station for every specimen: discard the used blade, clean the microtome (especially the collection surface and holder) and the bench with DNA cleaner followed by 70% ethanol, discard gloves, put on new gloves, insert a new blade, and place scrolls in a new sterile tube. Preparation for molecular testing is an HTL-only topic on the current ASCP outline.

Why not the others: Xylene (A) dissolves paraffin; it is not a DNA decontaminant, and a shared blade carries tissue fragments. A shared water bath (C) is a classic carryover route. Batch sorting (B) invites both contamination and mix-ups.

Source: IARC, SOP for Samples Preparation and Processing: Tissue and slides (Appendix 9.c, v4.2, Apr 2024), Section 1.3.2, Steps 2–3, 9–17, pp. 3–4; ASCP BOC HT/HTL Content Guideline (testing from Nov 1, 2026), Embedding/Microtomy D.5, p. 3.

C. 11 hours. Total time in fixative includes time in NBF at grossing and time on the processor's formalin station. 08:00 to 18:00 is 10 hours, plus 1 hour on the processor's NBF station = 11 hours. That falls inside the 6–72 hour window ASCO/CAP uses for ER, PgR and HER2.

Why not the others: A counts only the processor. B leaves out the processor's formalin station. D adds time after the tissue entered alcohol.

Calculation: (18:00 − 08:00) + 1 h = 10 h + 1 h = 11 h

Source: Dako/Agilent IHC Staining Methods, 6th ed., Ch. 2.2, "Grossing," p. 23 (processor time counts); Ch. 2.3, "10% NBF," p. 23 (6–72 hours).

D. Endogenous peroxidase activity. If DAB turns brown with no antibodies present, something in the tissue is acting on the peroxidase substrate. Blocking endogenous peroxidase with hydrogen peroxide (one manufacturer's protocol uses 3% H2O2 for 10 minutes before the primary) removes that signal.

Why not the others: Biotin (A) only matters with avidin- or streptavidin-biotin detection, and this run is biotin-free. No secondary (C) or primary (B) was applied to the slide that still stained.

Source: Cell Signaling Technology, IHC Troubleshooting Guide, "Peroxidase Quenching."

C. 120 mL. Ten to twenty times 8 mL is 80 to 160 mL; 120 mL is the only choice in range.

Why not the others: 40 mL (5×) and 60 mL (7.5×) are too little fixative. 250 mL is about 31×, outside the stated range.

Calculation: 8 mL × 10 = 80 mL; 8 mL × 20 = 160 mL; 120 mL ÷ 8 mL = 15×

Source: Dako/Agilent IHC Staining Methods, 6th ed., Ch. 2.2, "Grossing," p. 23.

B. Type II. In routine ATPase fiber typing, type II fibers stain darker at pH 9.4, and type I fibers stain darker at the acidic preincubation (pH 4.2). Enzyme histochemistry staining is an HTL-only topic.

Why not the others: Type I (A) shows the reverse pattern. C is wrong; this is exactly what ATPase at different pH values is for. D overreaches; one fiber's staining pattern doesn't establish denervation.

Source: Nix JS, Moore SA. What Every Neuropathologist Needs to Know: The Muscle Biopsy. J Neuropathol Exp Neurol. 2020;79(7):719–733, "Motor Units, Fiber Typing, and Other Light Microscopic Characteristics" and fiber-typing table.

D. Sections need to lie flat against the slide to prevent lifting during staining and bubble formation, which can trap staining reagents. With heat retrieval and many wash steps, that turns into tissue loss or uneven, artifactual staining.

Why not the others: Drying (A) doesn't remove the gap under the section. C overstates it; the effect is local. B is backwards; long IHC protocols with HIER are especially hard on poorly adhered sections.

Source: Dako/Agilent IHC Staining Methods, 6th ed., Ch. 2.4, "Section Preparation," p. 25.

C. If a specimen has to be decalcified, the time in fixative before decalcification, the decalcifier type, how long it was used, and any post-decalcification treatment should all be recorded. These details explain unexpected IHC or ISH results and guide protocol and control choices.

Why not the others: A and B leave out variables that change staining. D is false; decalcification is a recognized pre-analytical variable.

Source: Dako/Agilent IHC Staining Methods, 6th ed., Ch. 2.2, "Accessioning and Documentation," p. 22.

B. Switch to polymer-based detection, or add a biotin block. Kidney and liver are rich in endogenous biotin, which streptavidin binds directly, producing false staining with biotin-based detection. A polymer-based detection system avoids the problem; a biotin block is an alternative.

Why not the others: More primary (A) or longer DAB (C) would worsen background. The counterstain (D) has nothing to do with it.

Source: Cell Signaling Technology, IHC Troubleshooting Guide, "Biotin Block" and "Detection System."

C. The slide rule fails. CLIA requires histopathology slides to be retained at least 10 years and pathology specimen blocks at least 2 years from the date of examination. Pathology test reports must be retained at least 10 years after reporting. Three years for blocks meets the 2-year minimum; 5 years for slides does not meet 10.

Why not the others: A misses the slide shortfall. B reverses the block and slide periods. D is wrong because the block rule exceeds the minimum.

Source: 42 CFR 493.1105, Retention requirements, (a)(6)(ii), (a)(7)(i)(B), (a)(7)(ii).

C. At least 24 hours. The guidebook states that tissue 4 mm thick should be fixed for at least 24 hours at room temperature. The authors note that the ASCO/CAP minimum of 6 hours for breast biomarkers is a compromise for speed and argue for a 24-hour minimum. Know both numbers: 6–72 hours is the guideline window for ER, PgR and HER2; about 24 hours is the chemistry.

Why not the others: One hour (A) is penetration at best. Six hours (B) is the guideline minimum for breast biomarkers, not complete fixation chemistry. Seven days (D) risks over-fixation and masking.

Source: Dako/Agilent IHC Staining Methods, 6th ed., Ch. 2.3, "10% NBF," p. 23.

A. Bielschowsky silver. The Bielschowsky silver method is used in diagnosing Alzheimer disease to show the neuritic portions of plaques and tangles.

Why not the others: Trichrome (B) separates collagen and muscle. Alcian blue (C) shows acidic mucins. Prussian blue (D) shows ferric iron.

Source: Dako/Agilent Special Stains and H&E, 2nd ed., Ch. 1, Table 2 (Bielschowsky), p. 9.

D. RNases are everywhere, including on skin. RNA work calls for a designated area, frequent glove changes, benches cleaned with an RNase decontaminant such as RNaseZap, and RNase-free water, solutions, tubes and tips at every step. The "RNAase-free area" is named in the HTL-only molecular-testing topic on ASCP's outline.

Why not the others: Bare hands (A) are a major RNase source. Ordinary tap water (C) and shared routine reagents (B) aren't RNase-free.

Source: Carl Zeiss MicroImaging, "LCM Protocols – RNA handling" (Aug 2008), general RNA-handling guidance; ASCP BOC HT/HTL Content Guideline (testing from Nov 1, 2026), Embedding/Microtomy D.5, p. 3.

C. If IHC is regularly done on decalcified tissues, the lab should test enough of them to be sure assays consistently achieve expected results. The laboratory medical director decides how many positive and negative tissues, and which markers, to test.

Why not the others: A ignores a known pre-analytical variable. B invents a fixed number. D is false; decalcified specimens are tested routinely when validated.

Source: CAP, Principles of Analytic Validation of Immunohistochemical Assays: Guideline Update (Goldsmith et al., 2024), summary of statements, Statement 11.

B. AEC gives a bright red product that dissolves in alcohol and organic solvents, so AEC slides are mounted in an aqueous medium. Sending them through alcohols and xylene strips the signal you just developed.

Why not the others: The signal was present before mounting, so incubation (A) wasn't the problem. C names the wrong chromogen. A counterstain (D) doesn't erase chromogen.

Source: GeneTex, AEC Peroxidase Chromogen Substrate Kit (GTX30938) product page, product description.

D. Alcohol fixes by coagulating and precipitating proteins, extracts small carbohydrates, dehydrates the tissue (causing shrinkage and hardening), and usually eliminates the need for antigen retrieval. It initially penetrates and fixes faster than formalin, though penetration slows later, and it is often recommended for nucleic acid work.

Why not the others: Cross-linking (A) is formalin chemistry. Chelation (C) is EDTA decalcification. B is wrong; alcohol initially penetrates and fixes faster.

Source: Dako/Agilent IHC Staining Methods, 6th ed., Ch. 2.3, "Alcohol Fixation," p. 24.

D. For individuals performing high-complexity testing, CLIA requires performance evaluations at least semiannually during the first year of patient testing and at least annually after that. A change in method or instrument requires reevaluation before patient results are reported. Competency evaluation must include direct observation of routine testing, monitoring of result recording and reporting, review of worksheets, QC, proficiency testing and maintenance records, direct observation of maintenance and function checks, testing of previously analyzed or blind samples, and assessment of problem-solving skills.

Why not the others: A delivers one evaluation in the first year instead of two. C exceeds the requirement. B falls short of it.

Source: 42 CFR 493.1451, Technical supervisor responsibilities, (b)(8)(i)–(vi) and (b)(9).

B. CISH. CISH uses chromogens, so slides are read with bright-field microscopy, tissue morphology is visible for picking out invasive tumor, and slides can be stored long term. FISH needs a fluorescence microscope, and its signals fade, which makes long-term archiving impractical. In one multicenter study, dual-color CISH matched FISH HER2 status in every evaluable case and both report a HER2:CEN-17 ratio.

Why not the others: FISH (A) fails the bright-field and archiving requirements. Immunofluorescence (C) detects protein, not gene copy number, and also fades. Congo red (D) is an amyloid stain.

Source: García-Caballero T, et al. Determination of HER2 amplification in primary breast cancer using dual-colour CISH is comparable to FISH. Histopathology. 2010;56(4):472–480, Introduction, Results and Discussion.

B. IHC sections are normally picked up on slides coated with an adherent material and must lie flat against the glass to prevent lifting. Alkaline Tris-EDTA retrieval is harsher than citrate and can cause loss of tissue from the slide, so adhesion matters even more.

Why not the others: Uncoated glass (A) gives the section less to hold on to during harsh retrieval. Undried sections (C) lift. Thicker sections (D) cause staining and interpretation problems.

Source: Dako/Agilent IHC Staining Methods, 6th ed., Ch. 2.4, "Section Preparation," p. 25; Fortis Life Sciences, "Retrieval buffers: citrate vs Tris-EDTA", Tris-EDTA section.

D. Monoclonal antibodies are a single antibody against one epitope, giving high specificity, low cross-reactivity and strong batch-to-batch reproducibility. Polyclonal antibodies are a mixture against many epitopes on the antigen, which can boost sensitivity for scarce targets but brings batch variability and more cross-reactivity. Antibody preparation is an HTL-only topic.

Why not the others: A reverses the definitions. C ignores real differences. B overstates it; polyclonals often have the sensitivity edge for low-abundance proteins.

Source: Proteintech, "Polyclonal vs monoclonal antibodies", Monoclonal and Polyclonal sections.

B. In a published comparison, cell pellets fixed overnight in NBF kept Ki-67 and cyclin D1 immunoreactivity, while pellets sent straight into 70% alcohol without formalin fixation lost it. Under-fixed or unfixed tissue can lose nuclear antigens before or during processing; the guidebook also notes that under-fixation is generally more harmful than over-fixation.

Why not the others: There was no formalin, so over-fixation (A) is impossible. Retrieval (C) or chromogen (D) problems would affect the control too, and the history points straight at the missing fixation.

Source: Dako/Agilent IHC Staining Methods, 6th ed., Ch. 2.3, Fig. 2.4 and "10% NBF," pp. 23–24.

C. Cytology specimens that are not fixed the same way as the original validation tissue, such as alcohol-fixed cell blocks, smears and liquid-based preparations, need separate validations for every new analyte and fixation method before clinical use. CAP recommends at least 10 positive and 10 negative cases for each, documenting the rationale if that isn't feasible.

Why not the others: A ignores the change in fixation. B describes the minimum check for a new antibody lot of an already validated assay. D is false.

Source: CAP, Principles of Analytic Validation of IHC Assays: Guideline Update (2024), Statements 9–10.

A. Movat pentachrome. Movat's pentachrome demonstrates muscle, elastic fibers and collagen (with reticular fibers) simultaneously, which is why it's used for vessel walls and other connective tissue.

Why not the others: Gram (B) is for bacteria. Oil red O (C) is a frozen-section lipid stain. Prussian blue (D) shows iron.

Source: Dako/Agilent Special Stains and H&E, 2nd ed., Ch. 1, Table 2 (Movat pentachrome), p. 8.

C. A measurable objective states what the learner will do, with an observable action verb and an object, so it can be assessed. "Understand" (A) and "appreciate" (B) can't be observed directly. D describes the trainer's activity, not the learner's performance. Basic education principles are an HTL-only topic.

Source: Michigan Technological University, Center for Teaching and Learning, "Creating measurable and observable learning objectives", objective structure and example verbs.

A. Tissue should never dry out during handling or slide preparation for IHC or ISH. Drying can alter targets, particularly along tissue edges, and dry tissue is more adsorbent, which increases nonspecific adsorption of reagents and complicates interpretation.

Why not the others: B is not a real rule. C and D have no basis; the pattern points to drying.

Source: Dako/Agilent IHC Staining Methods, 6th ed., Ch. 2.2, Tissue Handling, p. 21.

C. A no-primary control isolates the secondary antibody and detection system. Staining on that slide means they are producing signal on their own, for example through secondary cross-reactivity, so the patient result can't be trusted until the cause is fixed. Control selection is an HTL-only topic.

Why not the others: No primary was applied, so its dilution (A) can't be the cause. The patient's antigen status (B) can't show up without the primary. Failed retrieval (D) would weaken staining, not create it.

Source: Cell Signaling Technology, IHC Troubleshooting Guide, "Secondary Cross-Reactivity."

A. Microwave energy accelerates reactions and penetration, but microwave fixation can be uneven depending on specimen size and composition and on the microwave. Microwaving tissue directly coagulates protein and can leave it hard or "overcooked." Instrumentation, including microwaves, sits under Fixation in the ASCP outline.

Why not the others: B is the opposite of the documented risk. C and D are unrelated to microwave fixation.

Source: Dako/Agilent IHC Staining Methods, 6th ed., Ch. 2.3, "Enhancing Fixation," p. 25.

A. Type I. Type I fibers are oxidative: they stain darker with NADH, SDH and COX, and darker with ATPase at pH 4.2, while type II fibers are darker with ATPase at pH 9.4. Pale at pH 9.4 plus dark oxidative stains points to type I.

Why not the others: Type II (B) shows the opposite ATPase pattern. C is wrong; these are the standard fiber-typing stains. D is wrong; the checkerboard pattern of normal muscle exists because fiber types differ.

Source: Nix & Moore, J Neuropathol Exp Neurol 2020, "Motor Units, Fiber Typing, and Other Light Microscopic Characteristics" and fiber-typing table.

D. Rapid processors that combine alternative fixatives with microwave-enhanced processing produce morphology that differs from routine formalin-fixed, paraffin-embedded tissue. IHC and ISH methods need complete revalidation, and some may not need heat or enzyme retrieval at all.

Why not the others: A ignores a major pre-analytical change. C misses the special-technique impact. B applies a blanket adjustment with no validation behind it.

Source: Dako/Agilent IHC Staining Methods, 6th ed., Ch. 2.4, "Rapid Tissue Processing," p. 25.

C. At least 2 known positive and 2 known negative tissues. CAP recommends confirming performance with at least 2 positive and 2 negative tissues when the antibody dilution, the antibody vendor (same clone), or incubation or retrieval times (same method) change.

Why not the others: 1 positive and 1 negative (B) is the check for a new lot of the same antibody. Full revalidation (D) is for a change of antibody clone. A skips a required check.

Source: CAP, Principles of Analytic Validation of IHC Assays: Guideline Update (2024), Statements 12, 13 and 15.

A. Giemsa. Giemsa stains H. pylori, along with organisms such as Plasmodium and Rickettsia.

Why not the others: Luxol fast blue (B) shows myelin. Von Kossa (C) shows calcium salts. Oil red O (D) shows neutral lipid.

Source: Dako/Agilent Special Stains and H&E, 2nd ed., Ch. 1, Table 2 (Giemsa), p. 5.

B. 375. Convert to the same unit: 1.5 mm = 1,500 µm. Then 1,500 µm ÷ 4 µm per section = 375 sections. This kind of check matters when a pathologist asks for levels or deeper sections on a small focus.

Why not the others: 37 and 3,750 (A, D) slip a decimal place in the mm-to-µm conversion. 600 (C) assumes 2.5-µm sections.

Calculation: 1.5 mm × 1,000 µm/mm = 1,500 µm; 1,500 ÷ 4 = 375

Source: Derived calculation; ASCP lists unit conversions under Laboratory Operations B.1 in the HT/HTL Content Guideline (testing from Nov 1, 2026), p. 4.

D. 18 × 15 × 4 mm. Trimmed blocks should not exceed 20 mm in length and width or 4–5 mm in depth. Size controls how evenly fixative and processing reagents penetrate.

Why not the others: A is too long and too thick. C is too thick. B is too long.

Source: Dako/Agilent IHC Staining Methods, 6th ed., Ch. 2.2, "Grossing," p. 23.

B. In labeled-polymer detection, a dextran backbone is labeled with both secondary antibodies and many enzyme molecules, so each binding event brings a lot of enzyme without using biotin. Polymer-based visualization is described as the most widely used IHC detection method today, valued for stability and sensitivity. Detection theory is an HTL-only topic.

Why not the others: A is the direct method. C is the PAP (unlabeled antibody) method. D is avidin- or streptavidin-biotin detection.

Source: Dako/Agilent IHC Staining Methods, 6th ed., Ch. 1.2, Fig. 1.3 and text, p. 14.

C. Enzyme histochemistry demonstrates the activity of enzymes in the tissue, so it is done on frozen sections. In a standard muscle biopsy protocol, NADH, SDH and COX/SDH run on frozen cryosections, while formalin- and glutaraldehyde-fixed portions go to paraffin, special stains and electron microscopy. Fixation and processing for enzyme histochemistry are tested on both HT and HTL; enzyme staining itself is HTL-only.

Why not the others: A and B aren't the reason. D is false; muscle is routinely paraffin-processed for other purposes.

Source: Dako/Agilent Special Stains and H&E, 2nd ed., Ch. 1, p. 5 (frozen sections for enzymes); Nix & Moore, J Neuropathol Exp Neurol 2020, "Optimizing the Muscle Biopsy."

A. Glass and coverslips have a refractive index of about 1.52. Resinous media dissolved in xylene or toluene come very close, giving fully transparent preparations where contrast comes only from the stain. Aqueous media are generally lower (glycerol about 1.47), so some unstained structure stays visible and detail drops. Refractive index is an HTL-only topic under Mounting Procedures.

Why not the others: B is false; many stains are mounted aqueously by design. C is false; resinous media sit close to glass. D is false; it affects bright-field optics.

Source: StainsFile, "Mounting Media", refractive index discussion.

D. The minimum necessary standard requires covered entities to take reasonable steps to limit protected health information used, disclosed or requested to what the purpose needs. A technical question about an artifact rarely needs any identifiers. The standard does not apply to disclosures to a provider for treatment, which isn't the situation here.

Why not the others: A sends far more than needed. C is false for covered laboratories. B overstates the treatment exception.

Source: HHS, Minimum Necessary Requirement.

B. When ice crystal artifact or poor orientation compromises a frozen muscle specimen, the specimen can be thawed, reprocessed and refrozen. Fibers may round, but proper orientation and elimination of ice crystals are much better than interpreting heavily damaged tissue.

Why not the others: A risks a misread. C sacrifices enzyme histochemistry. D doesn't remove the artifact.

Source: Nix & Moore, J Neuropathol Exp Neurol 2020, "Optimizing the Muscle Biopsy," Fig. 2.

B. The duration of trypsin or pepsin digestion needed is directly proportional to fixation time. In the guidebook's example, trypsin unmasked IgM at 8 and 32 hours but left it depleted at 56 and 104 hours, while high-pH HIER for 20 minutes at 97 °C gave about the same staining across all four. Extending trypsin would help the long-fixed tissue but damage the short-fixed tissue, which is why each new antigen needs this kind of comparison. Antigen retrieval is HTL-only.

Why not the others: A contradicts the good staining at 8 and 32 hours. C contradicts the HIER result. D ignores that the antigen was recoverable with HIER.

Source: Dako/Agilent IHC Staining Methods, 6th ed., Ch. 2.3, Fig. 2.5 and text, p. 24.

B. Isopentane is chilled in liquid nitrogen, stirred, and the mounted muscle is submerged once the isopentane reaches about −155 to −160 °C. The source calls frozen tissue the best preparation for diagnosis and recommends giving it priority.

Why not the others: Formalin first (A) defeats the purpose of frozen enzyme work. A −20 °C freezer (C) freezes far more slowly than this snap-freeze method. Michel medium (D) appears on ASCP's transport-media list, but it isn't how the frozen diagnostic portion of a muscle biopsy is prepared in this protocol.

Source: Nix & Moore, J Neuropathol Exp Neurol 2020, "Optimizing the Muscle Biopsy."

A. In the indirect (two-step) method, an unconjugated primary antibody binds the antigen, and an enzyme-labeled secondary antibody then binds the primary. In the direct (one-step) method, the primary carries the label. IHC terminology is tested on both HT and HTL.

Why not the others: B is the direct method. C and D don't describe IHC.

Source: Dako/Agilent IHC Staining Methods, 6th ed., Ch. 1.2, Fig. 1.3, p. 14; ASCP BOC HT/HTL Content Guideline (testing from Nov 1, 2026), Staining A.11.a, p. 3.

A. CAP advises validating with tissues processed using the same fixative and processing methods as clinical cases, when possible. Fixation and processing change antigenicity, so validating on differently handled tissue can misstate how the assay will perform.

Why not the others: B brings in uncontrolled variables. C and D can be useful comparators, but they don't replace tissue handled like clinical cases.

Source: CAP, Principles of Analytic Validation of IHC Assays: Guideline Update (2024), Statement 8.

A. Jones (periodic acid–methenamine silver, PAMS). The Jones basement membrane stain uses periodic acid–methenamine silver to visualize basement membranes.

Why not the others: Fontana-Masson (B) shows melanin and argentaffin material. Warthin-Starry (C) shows spirochetes and other bacteria. Von Kossa (D) shows calcium salts.

Source: Dako/Agilent Special Stains and H&E, 2nd ed., Ch. 1, Fig. 12 caption (Jones basement membrane stain), p. 17; ASCP BOC HT/HTL Content Guideline (testing from Nov 1, 2026), Summary of Stains, p. 6.

D. 2.94 g. Grams = molarity × molecular weight × liters = 0.01 × 294.10 × 1 = 2.941 g. (pH is adjusted afterward per the lab's procedure.)

Why not the others: 0.294 g (A) makes 0.001 M. 5.88 g (C) makes 0.02 M. 29.4 g (B) makes 0.1 M.

Calculation: g = M × MW × L = 0.01 × 294.10 × 1 = 2.941 g

Source: Derived calculation; ASCP lists molar solutions under Laboratory Operations D.3 in the HT/HTL Content Guideline (testing from Nov 1, 2026), p. 4.